ICUI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ICUI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, ICU Medical's PE Ratio without NRI is 48.64. ICU Medical's 5-Year EBITDA growth rate is 12.20%. Therefore, ICU Medical's PEG Ratio for today is 3.99.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for ICU Medical's PEG Ratio or its related term are showing as below:
During the past 13 years, ICU Medical's highest PEG Ratio was 778.75. The lowest was 1.64. And the median was 6.41.
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
The historical data trend for ICU Medical's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
PEG Ratio | Get a 7-Day Free Trial | 4.37 | 3.79 | 2.79 | - | - |
ICU Medical Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
PEG Ratio | Get a 7-Day Free Trial | 6.12 | 2.38 | - | 3.59 | 5.55 |
For the Medical Instruments & Supplies subindustry, ICU Medical's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's PEG Ratio distribution charts can be found below:
* The bar in red indicates where ICU Medical's PEG Ratio falls into.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.
ICU Medical's PEG Ratio for today is calculated as
PEG Ratio | = | PE Ratio without NRI | / | 5-Year EBITDA Growth Rate* |
= | 48.635866593767 | / | 12.20 | |
= | 3.99 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
ICU Medical (NAS:ICUI) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Thank you for viewing the detailed overview of ICU Medical's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Vivek Jain | director, officer: Chairman and CEO | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Daniel Woolson | officer: VP, GM-Infusion Capital | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Virginia Ruth Sanzone | officer: VP, General Counsel | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Christian B. Voigtlander | officer: Chief Operating Officer | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Elisha W Finney | director | C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304 |
George A Lopez | director, officer: Chairman, other: Chairman | C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Smiths Group International Holdings Ltd | 10 percent owner | C/O SMITHS GROUP PLC, 11-12 ST. JAMES'S SQUARE, 4TH FLOOR, LONDON X0 SW1Y 4LB |
Group Plc Smiths | 10 percent owner | 765 FINCHKEY ROAD, LONDON X0 00000 |
William Seeger | director | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Kolleen T Kennedy | director | VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304 |
Robert S Swinney | director | C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Laurie Hernandez | director | 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Brian Michael Bonnell | officer: Chief Financial Officer | ICU MEDICAL INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Scott E Lamb | officer: Controller | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
Kevin J Mcgrody | other: Controller | ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673 |
From GuruFocus
By GlobeNewswire • 03-01-2024
By PRNewswire PRNewswire • 02-08-2023
By PRNewswire • 08-29-2023
By GuruFocus Research • 09-12-2023
By GuruFocus Research • 06-17-2024
By Marketwired • 08-07-2024
By GuruFocus Research • 09-13-2024
By sperokesalga sperokesalga • 02-21-2023
By GuruFocus Research • 05-31-2024
By GuruFocus Research • 11-07-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.